With nearly $3.0B raised, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.

Life Sciences

Acquired by AstraZeneca in 2016
IPO in 2017 (NASDAQ: ANAB)
Acquired by Valeant Pharmaceuticals in 2014
Acquired by Allergan in 2016

Growth Buyout

Acquired by The Partners Group

News

PCI

Pharma Packager PCI Sells for More Than $1 Billion

Matrix Medical Network

Providence Service Corporation and Frazier Healthcare Partners Complete Formation of Strategic Partnership in Matrix Medical Network

Frazier Healthcare Partners

Frazier Healthcare Partners Promotes Three Life Sciences Investment Professionals

Alpine Immune Sciences

Nivalis Therapeutics and Alpine Immune Sciences Agree to Combine